Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 3INDIV 1

Study Type

Observational 3Interventional 1

Sponsor

Conditions

Myasthenia Gravis 4Carcinoma, Hepatocellular 2Skin Neoplasms 1Nervous System Diseases 1Melanoma 1Hepatitis 1Colitis 1Autoimmune Diseases 1Arthritis, Rheumatoid 1

Interventions

rozanolixizumab 11efgartigimod alfa 10zilucoplan 8Prednisone 8Cyclophosphamide 8ravulizumab 7Rituximab 7Pyridostigmine Bromide 7telitacicept 6fludarabine 6Tacrolimus 6Mycophenolic Acid 6eculizumab 5Immunoglobulins, Intravenous 5Hizentra 4Azathioprine 4Steroids 3HBM9161 3Data Collection 3Amifampridine 3thymoglobulin 2inebilizumab 2Thymectomy 2Prednisolone 2Methylprednisolone 2Methotrexate 2Exercise 2Diagnostic Self Evaluation 2Blood Specimen Collection 2tofacitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Myasthenia Gravis × Azathioprine × Clear all
NCT04182984 2026-01-30

TREAT-OMG

Tang-Du Hospital

Recruiting
200 enrolled

Myasthenia Gravis

NCT01727193 2022-04-14

The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy

First Affiliated Hospital, Sun Yat-Sen University

Phase 3 Completed
290 enrolled

Myasthenia Gravis

NCT04101578 2021-08-23

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Da, Yuwei, M.D.

Unknown
2,000 enrolled

Myasthenia Gravis

NCT03490539 2021-02-03

PROMISE-MG

Duke University

Completed
167 enrolled

Autoimmune Diseases, Myasthenia Gravis, Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡